+Compare
PYPD
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
6.78M

PYPD PolyPid Ltd Forecast, Technical & Fundamental Analysis

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sorrento Therapeutics (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.29B. The market cap for tickers in the group ranges from 402 to 464.61B. NVO holds the highest valuation in this group at 464.61B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 34%, and the average quarterly price growth was 20%. CDT experienced the highest price growth at 183%, while BRRGF experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 52%. For the same stocks of the Industry, the average monthly volume growth was 19% and the average quarterly volume growth was 54%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 59
SMR Rating: 94
Profit Risk Rating: 95
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

PYPD is expected to report earnings to fall 200.59% to -342 cents per share on February 07

PolyPid Ltd PYPD Stock Earnings Reports
Q4'23
Est.
$-3.42
Q3'23
Beat
by $7.56
Q2'23
Missed
by $0.05
Q1'23
Missed
by $0.02
Q4'22
Beat
by $0.09
The last earnings report on November 08 showed earnings per share of $3.40, beating the estimate of -415 cents. With 2.55K shares outstanding, the current market capitalization sits at 6.78M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
60
Web
https://www.polypid.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSPTX6.350.03
+0.47%
Transamerica Small Cap Growth I3
DSCLX13.510.04
+0.30%
DFA International Social Cor Eq Instl
AUIZX29.080.02
+0.07%
AB Equity Income Z
LSLTX32.66-0.11
-0.34%
Leuthold Select Industries
FUFRX19.90-0.15
-0.75%
Franklin Utilities R6

PYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYPD has been loosely correlated with VTYX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYPD jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+5.77%
VTYX - PYPD
37%
Loosely correlated
-3.04%
AMLX - PYPD
29%
Poorly correlated
+5.19%
INM - PYPD
28%
Poorly correlated
+21.74%
VRAX - PYPD
28%
Poorly correlated
-4.95%
GLPG - PYPD
26%
Poorly correlated
-0.65%
More

Groups containing PYPD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+5.77%
israel
(undefined stocks)
72%
Closely correlated
+5.13%
biopharmaceutical
(undefined stocks)
40%
Loosely correlated
+1.67%